Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models
Table 2
Mean half—Life of fosmetpantotenate and diastereomers after incubation with blood from various species at 37°C for 60 mina.